Prostate Cancer Highlights From the 2020 ASTRO Annual Meeting

<p><span data-sheets-value= "{"1":2,"2":"<p>This week, we're focusing on high-impact research in prostate cancer presented during the virtual 2020 ASTRO Annual Meeting. </p><p>The studies included a focus on GnRH receptor antagonist therapy; imaging-based guidance for radiotherapy intensification; and methods of radiotherapy boosts.</p><p>To listen to more podcasts from ASCO, visit <a href=\"https://www.asco.org/about-asco/asco-digital/podcasts\">asco.org/podcasts</a>. <br></p>"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This week, we're focusing on high-impact research in prostate cancer presented during the virtual 2020 ASTRO Annual Meeting. The studies included a focus on GnRH receptor antagonist therapy; imaging-based guidance for radiotherapy intensification; and methods of radiotherapy boosts.</span></p>